IN BRIEF: Payout Eyed At EKF On Covid Sample Collection Device Demand

Tue, 12th Jan 2021 11:47

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay manufacturer - Says in core business, trading in fourth quarter of 2020 continued to "improve significantly" helped by demand for the PrimeStore MTM Covid-19 sample collection device. "The company will pay a dividend again in December 2021 and expects to implement a progressive dividend policy," EKF adds.

Current stock price: 75.00 pence

Year-to-date change: up 4.5%

By Eric Cunha; ericcunha@alliancenews.com

Related Shares

More News

20 Mar 2024 12:04

EKF Diagnostics revenues, gross profits fall as expected

(Sharecast News) - EKF Diagnostics reported revenue of £52.6m in its final results on Wednesday, aligning with market projections, although lower...

20 Mar 2024 11:16

EKF Diagnostics says prospects "promising" but pauses dividends

(Alliance News) - EKF Diagnostics Holdings PLC on Wednesday said it swung to profit in its latest year despite revenue falling.

13 Mar 2024 14:47

UK earnings, trading statements calendar - next 7 days

29 Jan 2024 18:37

IN BRIEF: EKF Diagnostics reports trading in line with expectations

EKF Diagnostics Holdings PLC - Cardiff-headquartered medical diagnostics company - Trading update to December 31. Expects to report full-year revenue ...

11 Jan 2024 15:11

Director dealings: EKF Diagnostics director raises stake

(Sharecast News) - EKF Diagnostics revealed on Thursday that non-executive director Christopher Mills had acquired 100,000 shares in the AIM-listed gl...